International Drug Development Workshop 2016 (Molecules to Medicine: From Bench to Bedside to Marketing)
On 6 August 2016, the Faculty of Pharmaceutical Sciences at UCSI University held a one-day workshop on how new medicines are developed. Prima Nexus supported it.
· Workshop · Supported by Prima Nexus
About the workshop
The workshop was themed Molecules to Medicine: From Bench to Bedside to Marketing. It took place in the Le Quadri Ballroom at the North Wing of UCSI University's Kuala Lumpur campus. It was aimed at industrial pharmacists and at pharmaceutical researchers from research institutes. The organiser set three aims: to learn about the issues and challenges of drug development from industry leaders, to discuss case studies with peers, and to build global collaboration among experts in the pharmaceutical field.
Invited speakers
The organiser's invitation to supporters, sent before the workshop, listed three invited speakers and their topics. Professor Dr N. Sreeharan, a visiting professor at King's College London, was listed to speak on the issues and challenges in the search for new medicines. Professor Moses Chow of Western University of Health Sciences in the United States was listed to speak on the potential of herbal medicine for personalised cancer chemotherapy. Dr Sam Lim of the AstraZeneca Global Medicine Development Centre in China was listed to speak on the life cycle management of drugs.
Prima Nexus's part
Prima Nexus supported the workshop, and the Prima Nexus logo appeared with the other supporters on the event slides. Researchers who are developing new medicines today can read about Prima Nexus's animal study services.
More of our work with UCSI.
Read the story: Prima Nexus supported two drug development workshops in 2016, at UCSI University and IMR.
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.
